Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Ulcerative colitis and Crohn's disease are the two main forms of inflammatory bowel disease (IBD). Here we report the first trans-ancestry association study of IBD, with genome-wide or Immunochip genotype data from an extended cohort of 86,640 European individuals and Immunochip data from 9,846 individuals of East Asian, Indian or Iranian descent. We implicate 38 loci in IBD risk for the first time. For the majority of the IBD risk loci, the direction and magnitude of effect are consistent in European and non-European cohorts. Nevertheless, we observe genetic heterogeneity between divergent populations at several established risk loci driven by differences in allele frequency (NOD2) or effect size (TNFSF15 and ATG16L1) or a combination of these factors (IL23R and IRGM). Our results provide biological insights into the pathogenesis of IBD and demonstrate the usefulness of trans-ancestry association studies for mapping loci associated with complex diseases and understanding genetic architecture across diverse populations.

Original publication

DOI

10.1038/ng.3359

Type

Journal article

Journal

Nature genetics

Publication Date

09/2015

Volume

47

Pages

979 - 986

Addresses

Wellcome Trust Sanger Institute, Hinxton, UK.

Keywords

International Multiple Sclerosis Genetics Consortium, International IBD Genetics Consortium, Humans, Colitis, Ulcerative, Crohn Disease, Genetic Predisposition to Disease, Risk Factors, Case-Control Studies, Gene Frequency, Polymorphism, Single Nucleotide, Genome-Wide Association Study, Genetic Loci